GMAB Latest Headlines

Genmab’s Rina-S: New Study Targets Lung Cancer with Innovative Treatment

at www.tipranks.com (Wed, 17-Dec 11:31 AM)

Genmab's Rina-S Shows 50% Response Rate in Tough-to-Treat Endometrial Cancer—Phase 3 Trial Underway After FDA Breakthrough Designation

Market Chameleon (Mon, 20-Oct 7:08 AM)

Genmab’s $8 Billion Merus Acquisition Signals Major Expansion of Oncology Pipeline

Market Chameleon (Tue, 30-Sep 11:24 AM)

Genmab's $8 Billion Merus Acquisition Poised to Accelerate Pipeline and Revenue Growth

Market Chameleon (Mon, 29-Sep 7:12 AM)